Results 141 to 150 of about 38,942 (318)

Traitement des membranes néovasculaires myopiques par ranibizumab : résultats à long terme. [PDF]

, 2014
Background: To report our functional results of efficacy of intravitreal ranibizumab (IVR) for submacular choroidal neovessels (CNV) in high myopia, and to compare the role of optical coherence tomography (OCT), fluorescein angiography (FA) and visual ...
LADAIQUE, M.
core  

RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Retina, 2019
LUMINOUS study confirms the effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in real-world clinical practice.
F. Holz, M. Figueroa, F. Bandello, Yit Yang, M. Ohji, H. Dai, H. Wykrota, Sanjay Sharma, C. Dunger-Baldauf, Sue Lacey, W. Macfadden, P. Mitchell   +11 more
semanticscholar   +1 more source

GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration [PDF]

, 2016
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the ...
Altay, Lebriz, Baird, Paul N, Burdon, Kathryn Penelope, Chen, John, de Jong, Eiko K, den Hollander, Anneke I, Fauser, Sascha, Guymer, Robyn H, Hoyng, Carel B, Koenekoop, Robert K, Lores-Motta, Laura, Lu, Yi, MacGregor, Stuart, Montgomery, Grant W, Muether, Philipp, Omar, Amer, Riaz, Moeen, Richardson, Andrea J, Schick, Tina, Smailhodzic, Dzenita, van Asten, Freekje   +20 more
core   +2 more sources

Ranibizumab—The jury is still out [PDF]

Acta Paediatrica, 2020
Amy Keir, Amy Keir, Elizabeth Allen
openaire   +3 more sources

Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study [PDF]

, 2016
Purpose: The purpose of this study is to make a prospective evaluation of the effect of timolol 0.1% eye gel on short-term intraocular pressure (IOP) after an intravitreal injection (IVI) of ranibizumab. Participants and methods: One hundred and fifty
Allegrini, D., Dimastrogiovanni, A. F., Montesano, G., Pece, A.   +3 more
core   +3 more sources

pH of anti-VEGF agents in the human vitreous: low impact of very different formulations

International Journal of Retina and Vitreous, 2017
Background The aim of the study was to measure pH changes of the human vitreous caused by the intravitreal drugs bevacizumab, ranibizumab, aflibercept, and ziv-aflibercept.
Bianka Sobolewska, Peter Heiduschka, Karl-Ulrich Bartz-Schmidt, Focke Ziemssen   +3 more
doaj   +1 more source

Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom [PDF]

, 2017
PURPOSE: To evaluate the characteristics and racial variations amongst patients with polypoidal choroidal vasculopathy (PCV) in the United States and the United Kingdom.
Adelman, RA, Alasil, T, Baumal, CR, Coady, PA, de Carlo, TE, Duker, JS, Keane, PA, Munoz, N, Novais, E, Tufail, A, Waheed, NK   +10 more
core   +1 more source

The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective

PLoS ONE, 2018
Background The discussion on the use of bevacizumab is still ongoing and often doctors are deterred from using bevacizumab due to legal or political issues.
F. Asten, Charlotte T. J. Michels, C. Hoyng, Gert Jan Wilt, B., Jeroen B. Klevering, M. Rovers, J. Grutters   +7 more
semanticscholar   +1 more source

Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration [PDF]

, 2018
Purpose: The aim of this work is to investigate the characteristics of eyes failing to maintain visual acuity (VA) receiving variable dosing ranibizumab for neovascular age-related macular degeneration (nAMD) after three initial loading doses. Methods: A
Ambresin, Aude, Deli, Angeliki, Mantel, Irmela, Mariani, Alessandro   +3 more
core  

Characterization of Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Ranibizumab

Translational Vision Science & Technology, 2019
Purpose To characterize a biodegradable microsphere-hydrogel drug delivery system (DDS) for controlled and extended release of ranibizumab. Methods The degradable microsphere-hydrogel DDSs were fabricated by suspending ranibizumab-loaded or blank poly ...
Wenqiang Liu, Marta Arias Borrell, D. Venerus, W. Mieler, Jennifer J. Kang-Mieler   +4 more
semanticscholar   +1 more source